It’s been a rough several years for value investors. Atlantic Investment Management founder Alexander Roepers believes that is about to change. Since the financial crisis, value stocks — shares of ...
Fee pressure isn't the only problem asset managers are facing. The median spend for non-compensation costs — including regulatory expenses, technology, and office space — now accounts for nearly ...
Atlas Merchant Capital, co-founded by former Barclays chief executive officer Bob Diamond, is planning to raise a $1 billion private equity fund to invest in financial services firms, according to a ...
Private equity firms are planning to hire across their businesses, signaling no slowdown for an industry that has attracted a flood of capital from institutional investors, according to a poll taken ...
A rapidly changing macroeconomic environment appears to have left macro managers out in the cold. While many managed to avoid May’s stock market downdraft, so far they’re falling far behind the ...
The stock markets rose strongly over the first few months of 2019, but they’ve been struggling in recent weeks due to a resurgence of the trade war between the US and China. Meanwhile, bond yields are ...
Chris, I agree with your premise: Capitalism is failing a majority of market participants, and that failure is expressed as enormous inequality in the distribution of wealth in the U.S. However, I ...
You might think that companies that are being investigated for financial fraud by the Securities and Exchange Commission would be better off being straight with their investors about it — but you'd be ...
JPMorgan Chase & Co. is the latest financial firm to develop risk and portfolio management software for institutional investors. JPMorgan’s corporate and investment bank has partnered with StatPro — a ...
After a lengthy search process, the CFA Institute has selected its next chief executive officer and president, the group announced Monday. Margaret Franklin — who currently works in a leadership role ...
Hamilton Lane has closed a $1.7 billion co-investment fund, the fourth of its kind for the alternative asset manager. The fund will invest equity in buyouts and growth capital deals, putting money to ...
Biopharma IPO mania continues. At least three biopharmaceutical companies with hedge fund investors are planning to go public this week, two of which count Viking Global Investors as a significant ...